Advertisement

Topics

MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board

07:30 EDT 3 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
MetaStat, Inc. (OTCQB:MTST), a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients, announced today accomplished drug developer, Renato T. Skerlj, Ph.D., has joined the co...

Other Sources for this Article

MetaStat, Inc.
Rick Pierce, 617-531-0874
VP Investor Relations
rpierce@metastat.com

NEXT ARTICLE

More From BioPortfolio on "MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board"

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...